{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T03:02:09Z","timestamp":1791774129393,"version":"4.3.4"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Life Sciences"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.lfs.2020.117652","type":"journal-article","created":{"date-parts":[[2020,4,9]],"date-time":"2020-04-09T20:24:39Z","timestamp":1586463879000},"page":"117652","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":319,"special_numbering":"C","title":["In silico studies on therapeutic agents for COVID-19: Drug repurposing approach"],"prefix":"10.1016","volume":"252","author":[{"given":"Bhumi","family":"Shah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Palmi","family":"Modi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sneha R.","family":"Sagar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lfs.2020.117652_bb0005","first-page":"102433","article-title":"The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak","author":"Hussin","year":"2020","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.lfs.2020.117652_bb0010","article-title":"Research and Development on therapeutic agents and vaccines for COVID-19 and related human coronavirus diseases","author":"Cynthia","year":"2020","journal-title":"ACS Cent. Sci."},{"key":"10.1016\/j.lfs.2020.117652_bb0015","doi-asserted-by":"crossref","DOI":"10.1093\/jtm\/taaa008","article-title":"Pneumonia of unknown etiology in Wuhan, China: potential for international spread via commercial air travel","author":"Bogoch","year":"2020","journal-title":"J. Trav. Med."},{"key":"10.1016\/j.lfs.2020.117652_bb0020","series-title":"Coronavirus Disease (COVID-2019) Situation Reports-61, 21 March 2020","author":"Organization WH","year":"2020"},{"key":"10.1016\/j.lfs.2020.117652_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.117477","article-title":"Anti-HCV, nucleotide inhibitors, repurposing against COVID-19","volume":"248","author":"Elfiky","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.lfs.2020.117652_bb0030","doi-asserted-by":"crossref","DOI":"10.1126\/science.abb2507","article-title":"Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation","author":"Wrapp","year":"2020","journal-title":"Sci"},{"key":"10.1016\/j.lfs.2020.117652_bb0035","article-title":"Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host\u2212virus interaction, and proposed neurotropic mechanisms","author":"Abdul","year":"2020","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.lfs.2020.117652_bb0040","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ijsu.2020.02.034","article-title":"World Health Organization declares global emergency: a review of the 2019 novel coronavirus (COVID-19)","volume":"76","author":"Catrin","year":"2020","journal-title":"Int. J. Surg."},{"key":"10.1016\/j.lfs.2020.117652_bb0045","article-title":"New insights on the antiviral effects of chloroquine against coronavirus:what to expect for COVID-19?","author":"Christian","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"issue":"3","key":"10.1016\/j.lfs.2020.117652_bb0050","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1128\/CMR.00102-15","article-title":"Approved antiviral drugs over the past 50 years","volume":"29","author":"Clercq","year":"2016","journal-title":"Clin. Microbiol. Rev."},{"issue":"2","key":"10.1016\/j.lfs.2020.117652_bb0055","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/jac\/29.2.97","article-title":"Clinical trials of antiviral agents","volume":"29","author":"David","year":"1992","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.lfs.2020.117652_bb0060","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.jpha.2017.07.006","article-title":"Novel ligand-based docking; molecular dynamic simulations; and absorption, distribution, metabolism, and excretion approach to analyzing potential acetylcholinesterase inhibitors for Alzheimer's disease","volume":"8","author":"Subramaniyan","year":"2018","journal-title":"J Pharm Anal"},{"key":"10.1016\/j.lfs.2020.117652_bb0065","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.bioorg.2019.02.044","article-title":"Structure-based design, synthesis and biological evaluation of a newer series of pyrazolo [1, 5-a] pyrimidine analogues as potential anti-tubercular agents","volume":"87","author":"Modi","year":"2019","journal-title":"Bioorg. Chem."},{"issue":"3","key":"10.1016\/j.lfs.2020.117652_bb0070","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s11030-012-9387-9","article-title":"A rational approach to selective pharmacophore designing: an innovative strategy for specific recognition of Gsk3b","volume":"16","author":"Pradeep","year":"2012","journal-title":"Mol. Divers."},{"key":"10.1016\/j.lfs.2020.117652_bb0075","series-title":"PanDDA Analysis Group Deposition \u2013 Crystal Structure of COVID-19 Main Protease in Complex with Z45617795","author":"Fearon","year":"2020"},{"key":"10.1016\/j.lfs.2020.117652_bb0080","series-title":"PanDDA Analysis Group Deposition -- Crystal Structure of COVID-19 Main Protease in Complex with Z1220452176","author":"Fearon","year":"2020"},{"key":"10.1016\/j.lfs.2020.117652_bb0085","series-title":"PanDDA Analysis Group Deposition -- Crystal Structure of COVID-19 Main Protease in Complex with Z18197050","author":"Fearon","year":"2020"},{"key":"10.1016\/j.lfs.2020.117652_bb0090","series-title":"PanDDA Analysis Group Deposition -- Crystal Structure of COVID-19 Main Protease in Complex with Z1367324110, Protein Data Bank","author":"Fearon","year":"2020"},{"key":"10.1016\/j.lfs.2020.117652_bb0095","series-title":"PanDDA Analysis Group Deposition -- Crystal Structure of COVID-19 Main Protease in Complex with Z219104216","author":"Fearon","year":"2020"},{"key":"10.1016\/j.lfs.2020.117652_bb0100","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.ijbiomac.2019.08.061","article-title":"Structure-based identification of novel sirtuin inhibitors against triple negative breast cancer: an in silico and in vitro study","volume":"140","author":"Sinha","year":"2019","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.lfs.2020.117652_bb0105","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1021\/jm030644s","article-title":"Glide: a new approach for rapid, accurate docking and scoring 2. Enrichment factors in database screening","volume":"47","author":"Halgren","year":"2004","journal-title":"J. Med. Chem."},{"issue":"2","key":"10.1016\/j.lfs.2020.117652_bb0110","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s11030-013-9497-z","article-title":"Dual inhibitors of Janus kinase 2 and 3 (JAK2\/3): designing by pharmacophore- and docking-based virtual screening approach","volume":"18","author":"Jasuja","year":"2014","journal-title":"Mol. Divers."},{"key":"10.1016\/j.lfs.2020.117652_bb0115","doi-asserted-by":"crossref","first-page":"3407","DOI":"10.1038\/s41598-019-39939-z","article-title":"Merits and pitfalls of conventional and covalent docking in identifying new hydroxyl aryl aldehyde like compounds as human IRE1 inhibitors","volume":"9","author":"Carlesso","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.lfs.2020.117652_bb0120","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3389\/fchem.2018.00138","article-title":"Reverse screening methods to search for the protein targets of chemopreventive compounds","volume":"6","author":"Hongbin","year":"2018","journal-title":"Front. Chem."},{"key":"10.1016\/j.lfs.2020.117652_bb0125","series-title":"Maestro 11.4","year":"2017"},{"issue":"2","key":"10.1016\/j.lfs.2020.117652_bb0130","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1080\/1062936X.2019.1566172","article-title":"Identification of potential CRAC channel inhibitors: pharmacophore mapping, 3D-QSAR modelling, and molecular docking approach","volume":"30","author":"Bhuvaneshwari","year":"2019","journal-title":"SAR QSAR Environ. Res."},{"issue":"68","key":"10.1016\/j.lfs.2020.117652_bb0135","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.rmu.2015.05.003","article-title":"History and progress of antiviral drugs: from acyclovir to direct-acting antiviral agents (DAAs) for Hepatitis C","volume":"17","author":"Marrugo","year":"2015","journal-title":"Medicina universitaria"},{"key":"10.1016\/j.lfs.2020.117652_bb0140","article-title":"A trial of lopinavir\u2013ritonavir in adults hospitalized with severe Covid-19","author":"Bin","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.lfs.2020.117652_bb0145","doi-asserted-by":"crossref","first-page":"104786","DOI":"10.1016\/j.antiviral.2020.104786","article-title":"Remdesivir, lopinavir, emetine, and homoharringtonine inhibit SARS-CoV-2 replication in vitro","author":"Choy","year":"2020","journal-title":"Antivir. Res."},{"key":"10.1016\/j.lfs.2020.117652_bb0150","unstructured":"T. Smith, J. Bushek, T. Prosser, COVID-19 Drug Therapy. Clinical Drug Information, Clinical Solutions."},{"key":"10.1016\/j.lfs.2020.117652_bb0155","doi-asserted-by":"crossref","first-page":"117592","DOI":"10.1016\/j.lfs.2020.117592","article-title":"Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): a molecular docking study","author":"Elfiky","year":"2020","journal-title":"Life Sci."},{"key":"10.1016\/j.lfs.2020.117652_bb0160","unstructured":"L. Zhang, R. Zhou, Binding Mechanism of Remdesivir to SARS-CoV-2 RNA Dependent RNA Polymerase. Preprints. 10.20944\/preprints202003.0267.v1."},{"key":"10.1016\/j.lfs.2020.117652_bb0165","article-title":"Aromatic thiosemicarbazones, their antiviral action and interferon. 1. The decreasing of adenovirus type 1 resistance against interferon by methisazone in vitro","author":"Yuriy","year":"1996","journal-title":"\u0411\u0438\u043e\u043f\u043e\u043b\u0438\u043c\u0435\u0440\u044b \u0438 \u043a\u043b\u0435\u0442\u043a\u0430"},{"issue":"28","key":"10.1016\/j.lfs.2020.117652_bb0170","doi-asserted-by":"crossref","first-page":"3261","DOI":"10.2174\/0929867321666140706125950","article-title":"ABT-450: a novel protease inhibitor for the treatment of hepatitis C virus infection","volume":"21","author":"Ivan","year":"2014","journal-title":"Curr. Med. Chem."}],"container-title":["Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320520304008?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0024320520304008?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T20:31:59Z","timestamp":1758400319000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0024320520304008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":34,"alternative-id":["S0024320520304008"],"URL":"https:\/\/doi.org\/10.1016\/j.lfs.2020.117652","relation":{},"ISSN":["0024-3205"],"issn-type":[{"value":"0024-3205","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In silico studies on therapeutic agents for COVID-19: Drug repurposing approach","name":"articletitle","label":"Article Title"},{"value":"Life Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lfs.2020.117652","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"117652"}}